| pubmed-article:20920984 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0027625 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0242957 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0677930 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C2709058 | lld:lifeskim |
| pubmed-article:20920984 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:20920984 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:20920984 | pubmed:dateCreated | 2010-10-5 | lld:pubmed |
| pubmed-article:20920984 | pubmed:abstractText | HER2/neu status of tumor cells at metastatic sites in patients with advanced disease may differ from that of the primary tumor. Assessing the presence of target antigens on circulating tumor cells (CTCs) might affect treatment choice. | lld:pubmed |
| pubmed-article:20920984 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20920984 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20920984 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20920984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20920984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20920984 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20920984 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:20920984 | pubmed:issn | 1938-0666 | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:MinchellaIdaI | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:GoldhirschAro... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:CuriglianoGiu... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:SandriMaria... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:ZorzinoLauraL | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:CasadioChiara... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:BotteriEdoard... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:MunzoneElisab... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:AdamoliLauraL | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:EspositoAngel... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:CassatellaMar... | lld:pubmed |
| pubmed-article:20920984 | pubmed:author | pubmed-author:NoléFrancoF | lld:pubmed |
| pubmed-article:20920984 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20920984 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20920984 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:20920984 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20920984 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20920984 | pubmed:pagination | 392-7 | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:meshHeading | pubmed-meshheading:20920984... | lld:pubmed |
| pubmed-article:20920984 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20920984 | pubmed:articleTitle | Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer. | lld:pubmed |
| pubmed-article:20920984 | pubmed:affiliation | Division of Medical Oncology, European Institute of Oncology, Milan, Italy. elisabetta.munzone@ieo.it | lld:pubmed |
| pubmed-article:20920984 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:2064 | entrezgene:pubmed | pubmed-article:20920984 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20920984 | lld:entrezgene |
